Vyriad announced $25M final tranche of its Series B to support the first-in-human testing of VV169, Vyriad’s in vivo CAR-T candidate.

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

The achievements and discoveries in science and technology have not only profoundly reshaped how we live but also given us the confidence to confront challenges and embrace the future. Science and ...

In August, the corpses of four men were found along the banks of the river in Val-de-Marne, just outside Paris. Le Monde ...

No one knows exactly when Terrence Butler began keeping a journal, but there is a best guess. The first and only time someone ...

AI maps fleeting DNA quadruplexes, revealing paired structures that control genes in healthy cells and cancer.

The Institute of Cancer Research has led a study showing that chromosomal instability in circulating tumour cells can predict resistance to cabazitaxel in men with advanced prostate cancer. Using ...

The National Medical Commission (NMC) has released the official NEET UG 2026 syllabus, outlining the topics to be covered in ...